TrialCancer2017

Comparison of an AC-taxane versus AC-free regimen and paclitaxel versus docetaxel in patients with lymph node-positive breast cancer: Final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial, a randomized comparative phase 3 study.

Toru Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.